Thus, further studies of secretory molecules, such as TSP-1, from glial cells are required to identify clinically effective therapeutics in many CNS disorders by improving the general CNS environment in which the neuron can maintain cellular viability consistently. Here, THBS1 is linked to central nervous system disorder.